IL1B and Alzheimer disease: Consistent with these previous findings, our results demonstrate that NGO injection reduces IL1β production by DCs during OVA-induced AD-like skin inflammation (Figure S1), prompting us to speculate that DCs might be one of the target cells of NGO action.